Diasorin
A global leader in In Vitro Diagnostics for immunodiagnostics and molecular diagnostics.
DIA | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0003492391 (+2 more)
- LEI:
- 8156002878BDF0EE4348
- Country:
- Italy
- Address:
- VIA CRESCENTINO, SNC, 13040 SALUGGIA
- Website:
- https://diasoringroup.com/en
- Sector:
- Manufacturing
Description
Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-23 12:35 |
Pubblicazione della documentazione per l'Assemblea del 27 gennaio 2026
|
Italian | 218.5 KB | ||
| 2025-12-22 17:36 |
Diasorin S.p.A. - 2026 Annual Calendar of Corporate Events
|
Italian | 206.4 KB | ||
| 2025-12-22 17:34 |
Diasorin S.p.A. - Calendario Annuale Eventi Societari 2026
|
Italian | 266.4 KB | ||
| 2025-12-22 17:21 |
Publication of documents for the Shareholders’ Meeting to be held on January 27…
|
English | 230.4 KB | ||
| 2025-12-22 17:20 |
Pubblicazione della documentazione per l'Assemblea del 27 gennaio 2026
|
Italian | 54.4 KB | ||
| 2025-12-22 16:46 |
Shareholders' Meeting January 27, 2026 – Designated Representative proxy form (…
|
English | 242.5 KB | ||
| 2025-12-22 16:44 |
Assemblea degli Azionisti del 27 gennaio 2026 – Modulo delega Rappresentante De…
|
Italian | 261.1 KB | ||
| 2025-12-22 16:42 |
Shareholders' Meeting January 27, 2026 – Designated Representative proxy form (…
|
English | 297.6 KB | ||
| 2025-12-22 16:41 |
Assemblea degli Azionisti del 27 gennaio 2026 – Modulo delega Rappresentante De…
|
Italian | 296.3 KB | ||
| 2025-12-22 16:37 |
Shareholders' Meeting January 27, 2026 - Reports and motions for resolutions
|
English | 261.7 KB | ||
| 2025-12-22 16:34 |
Assemblea degli Azionisti 27 gennaio 2026 – Relazioni Illustrative e proposte d…
|
Italian | 294.6 KB | ||
| 2025-12-22 16:30 |
Diasorin S.p.A. - Shareholders' Meeting January 27, 2026 - Notice of call
|
English | 199.0 KB | ||
| 2025-12-22 16:29 |
Diasorin S.p.A. – Assemblea degli Azionisti 27 gennaio 2026 – Avviso di convoca…
|
Italian | 224.9 KB | ||
| 2025-12-22 14:27 |
The Board of Directors approved to submit to the Shareholders' Meeting the auth…
|
English | 216.4 KB | ||
| 2025-12-22 14:22 |
Il Consiglio di Amministrazione ha approvato di sottoporre all'Assemblea l'auto…
|
Italian | 222.9 KB |
Automate Your Workflow. Get a real-time feed of all Diasorin filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Diasorin
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Diasorin via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
